Drugs / gp160 MN/LAI-2
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00031109 | ? → May 2005 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | gp160 MN/LAI-2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00031109 ↗ |
| Modality | Vaccine | “recombinant gp160MN/LAI-2 vaccine” NCT00031109 ↗ |